Has Moussa Mansour, MD received payments from drug or device companies?

Yes. Drug and device makers reported $145,395 in general payments to Moussa Mansour, MD across 225 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Moussa Mansour, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Moussa Mansour, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Moussa Mansour, MD

Clinical Cardiac Electrophysiology · Boston, MANPI 1588649560

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Biosense Webster, Inc. at 47.5% of the total. Reporting peaked in 2024 at $30,544 and has fallen 70.6% since, to $8,967 in 2025. Among clinical cardiac electrophysiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$145,395in general payments, 2019–2025

Across 225 payments — averaging $646.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biosense Webster, Inc.$69K
Boston Scientific$30K
Medical Device Business Services, Inc.$17K
Abbott$9K
Medtronic$7K
Baylis Medical Company Inc$7K
plus $5K from 2 others

$3,659,980in research payments, 2019–2025

Across 337 payments — averaging $10,860 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Biosense Webster, Inc.$1.7M
Boston Scientific$1.1M
Medical Device Business Services, Inc.$263K
Abbott$200K
Adagio Medical, Inc.$174K
Medtronic$101K
plus $68K from 3 others

What the payments were for

Consulting fees$63,17543%
Speaking & faculty fees$12,7639%
Grants$1,5001%
Travel & lodging$54,94338%
Food & beverage$13,0159%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biosense Webster, Inc.	85	$69,122
Boston Scientific	69	$30,126
Medical Device Business Services, Inc.	10	$17,325
Abbott	39	$9,388
Medtronic(3 entities)	15	$7,478
Baylis Medical Company Inc	3	$7,363
Philips North America LLC	2	$4,357
Biotronik Inc.	2	$236

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Carto 3$31,525
Thermocool SF$24,926
Watchman$10,647
Carto 3 System$9,084
Navistar$9,029
WATCHMAN Access System$6,687
Ensite Cardiac Mapping System$6,110
Spectranetics Undiv$4,225
GENERAL EP$4,000
NRG needle$3,325
VersaCross Access Solution$2,375
GENERAL - THERAPIES$2,119
Farapulse$1,869
Reveal LINQ$1,800
VersaCross$1,663
TactiCath Quartz CFA Catheter$1,600
CLINICAL TRIAL PRODUCT$800
TACTICATH ABLATION CATHETER, SENSOR ENABLED$284
KYPHON Balloon Kyphoplasty$174
LINQ II$167

How this compares

$145,395 in reported general payments places this provider in the 90th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$602,971

Medicare patients

2,062

Services billed

3,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	71	$105,232
Metoprolol Succinate	52	$976
Prednisone	12	$25

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Boston

Elad AnterBoston$3.9M
Jagmeet SinghBoston$619K
Andre DavilaBoston$379K
Daniel KramerBoston$247K
Gregory MichaudBoston$244K
Laurence EpsteinBoston$172K
Leon PtaszekBoston$168K
Andrew LockeBoston$145K
Peter ZimetbaumBoston$144K
Timothy MaherBoston$123K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →